-
Veozah Liver Injury Drug Safety Communication Issued by FDA in September 2024
August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests (Posted by Tom Lamb at Drug Injury Watch) UPDATE: January 2025 Dear Healthcare Professional letter sent by Astellas Pharma Ltd. in…
-
Syfovre Injections Side Effects Legal Compensation Cases Being Filed for Patients
Drug Company Apellis Failed to Warn About Retinal Vasculitis Until a November 2023 Label Change (Posted by Tom Lamb at Drug Injury Watch) We are handling Syfovre injections side effects legal compensation cases being filed…
-
Wegovy, Rybelsus, and Ozempic Eye Side Effects: Semaglutide Linked to NAION
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), or "Eye Stroke", Can Cause Vision Loss (Posted by Tom Lamb at Drug Injury Watch) Wegovy, Rybelsus, and Ozempic eye side effects are possible given the recent findings that…
-
Syfovre Safety-Benefit Assessment by Europe’s Drug Regulator Differs From FDA
EMA’s CHMP Does Not Approve Syfovre for a Second Time, Citing "significant risk of adverse events" (Posted by Tom Lamb at Drug Injury Watch) There seems to be some disagreement about the Syfovre safety-benefit assessment…
